Amy Chan-Daniels

Amy Chan-Daniels is a seasoned professional in the pharmaceutical and biotechnology industries, currently serving as the Director of Clinical Science at Alnylam Pharmaceuticals since January 2023. Previously, Amy held the position of Director of Regulatory Affairs at Intellia Therapeutics, Inc. and served as Associate Director of Regulatory Affairs at Generation Bio. Amy's extensive career at Alnylam Pharmaceuticals spanned over 13 years, during which roles included Associate Director of Regulatory Affairs, Associate Director of Research, Principal Scientist, Senior Scientist, and Scientist. Prior experiences include research and animal care roles at UMASS Lowell and the Research Institute on Addictions. Amy's educational background includes a PhD and MS in Biomedical Engineering and Biotechnology from the University of Massachusetts Lowell and a BS in Biomedical Sciences from the University at Buffalo.